Sale!

UDAPA M 5/500 XR TABLET

Original price was: ₹83.40.Current price is: ₹70.89.

Availability: 36 in stock

UDAPA M 5/500 XR TABLET

Dapagliflozin 5mg + Metformin 500mg

USV Ltd

Guaranteed Safe Checkout

💊 Dapagliflozin 5mg + Metformin 500mg Tablet: Comprehensive Overview

Introduction
Dapagliflozin 5mg + Metformin 500mg is a combination oral antidiabetic medication primarily used to manage type 2 diabetes mellitus in adults. This dual-drug therapy helps improve glycemic control when diet and exercise alone are insufficient. It belongs to a class of drugs that address blood sugar levels through complementary mechanisms.


Composition and Mechanism of Action

  1. Dapagliflozin (5mg):
    A sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by preventing glucose reabsorption in the kidneys, promoting glucose excretion through urine, thus lowering blood glucose levels.

  2. Metformin Hydrochloride (500mg):
    A biguanide class agent. It decreases hepatic glucose production, improves insulin sensitivity, and increases peripheral glucose uptake without causing significant hypoglycemia.

Together, this combination improves glycemic control more effectively than either drug alone and may offer added benefits such as weight reduction and cardiovascular protection.


Uses

  • Primary Use: Management of Type 2 Diabetes Mellitus in adults.

  • Often prescribed when monotherapy with metformin or dapagliflozin is inadequate.

  • May also help reduce the risk of heart failure and renal complications in diabetic patients with coexisting cardiovascular or renal disease.


Dosage & Administration

  • Typical Dose: One tablet (5mg/500mg) once or twice daily with meals.

  • Adjustment: Based on patient’s tolerance, renal function, and blood glucose response.

  • Important Note: Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.


Common Side Effects

  • Metformin-related: Gastrointestinal upset (nausea, diarrhea, abdominal discomfort), vitamin B12 deficiency.

  • Dapagliflozin-related: Urinary tract infections, genital mycotic infections, increased urination, dehydration.

  • Serious Risks (Rare):

    • Lactic acidosis (associated with metformin)

    • Ketoacidosis (even with normal blood glucose)

    • Acute kidney injury

    • Hypotension (due to volume depletion)


Precautions

  • Renal Impairment: Dose adjustment or avoidance may be necessary.

  • Elderly Patients: Greater risk of dehydration and renal issues; monitor closely.

  • Before Surgery or Contrast Imaging: Metformin should be temporarily discontinued.

  • Pregnancy & Breastfeeding: Not generally recommended; consult a physician.

  • Hydration: Encourage adequate fluid intake to prevent dehydration and related complications.


Drug Interactions

  • Alcohol: Increases the risk of lactic acidosis.

  • Diuretics & NSAIDs: May enhance the risk of renal impairment.

  • Other Antidiabetics: Caution with agents that cause hypoglycemia (e.g., sulfonylureas, insulin).


Storage

  • Store at room temperature (15°C–30°C), away from moisture and heat.

  • Keep out of reach of children.


Conclusion
The Dapagliflozin 5mg + Metformin 500mg tablet is an effective fixed-dose combination therapy for patients with type 2 diabetes. Its dual action targets both insulin resistance and glucose excretion pathways, making it a valuable option for improved glycemic control with additional metabolic and cardiovascular benefits. However, patient selection, regular monitoring, and awareness of potential side effects are critical to its safe and effective use.

Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult a healthcare provider for personalized guidance.

Tablet

Reviews

There are no reviews yet.

Be the first to review “UDAPA M 5/500 XR TABLET”

Your email address will not be published. Required fields are marked *

Shopping Cart
Scroll to Top